Amano M, Maeda K, Tsuchiya K, Shimada S, et al. Third-dose BNT162b2 vaccination elicits markedly high-level SARS-CoV-2-neutralizing antibodies in vaccinees who poorly responded to second dose in Japan. J Infect Dis 2022 May 17. pii: 6587098. doi: 10.1093.
PMID: 35580786